Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak

April 5, 2021 updated by: Pınar Ciddi, Medipol University

Evaluation of Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak

The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working. In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported. Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working.

In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported.

Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.

Data collection is planned to take place in February-March 2021.

Surveys will be distributed via WhatsApp, e-mail, social media links. This questionnaire was sent to 3 physiotherapists and subjected to a pre-test. This questionnaire is about the following situations and contains 37 questions:

Information on employment status: In this section, physiotherapists' name-surname, gender, age, professional practice experience (years), generally applied physiotherapy subgroup (more than one can be selected), whether they are self-employed or employees, and the status of performing face-to-face clinical practices will be questioned. If so, it will be questioned which protection measures have been applied.

Information about tele-rehabilitation practices: In this section, it will be questioned whether physiotherapists start to follow their patients remotely, if they are, in what way they do it, whether the number of weekly sessions continues, and whether the amount collected is the same as the face-to-face amount.

General information about COVID 19 rehabilitation: In this section, did the departments where physiotherapists work returned to COVID 19 services, did they work in COVID 19 units, rehabilitation approaches in COVID 19 patients, protocol and / or guidelines on exercises for rehabilitation management and treatment of COVID 19 patients. material development / implementation status will be questioned.

The impact of the pandemic on the health and teaching activities of physiotherapists and the sustainability of clinical / thesis studies during this period will be questioned.

Finally, the CES Depression Scale (Center for Epidemiologic Studies Depression Scale, CES-D) will be used to determine depression level, the Generalized Anxiety Disorder 7 (GAD-7) Test will be used to evaluate generalized anxiety level, Perceived Stress Scale (PSS) will be used to determine stress level.

Study Type

Observational

Enrollment (Actual)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beykoz
      • Istanbul, Beykoz, Turkey, 34815
        • Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.

Description

Inclusion Criteria:

Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.

Exclusion Criteria:

Not meeting the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Physiotherapists
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A questionnaire created by research physiotherapists based on researches and examples in the literature.
Time Frame: The evaluation will take place in one interview (the interview will take 30 minutes)
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
The evaluation will take place in one interview (the interview will take 30 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of depression level with Center for Epidemiologic Studies Depression Scale
Time Frame: The evaluation will take place in one interview (the interview will take 30 minutes)
The Center for Epidemiologic Studies Depression Scale will be used to determine depression level. The scale consists of 20 questions in the form of a self-report that measure the emotional state of the person in depression, perceptions and behaviors towards depression. 4-point Likert type questionnaire with 0-60 points range is encoded in 0-3 points range.
The evaluation will take place in one interview (the interview will take 30 minutes)
Assessment of anxiety level with Generalized Anxiety Disorder 7 Test
Time Frame: The evaluation will take place in one interview (the interview will take 30 minutes)
The Generalized Anxiety Disorder 7 test will be used to determine anxiety level. It is a 7-item four-point Likert (0 = none, 1 = many days, 2 = more than half of the days, 3 = almost every day), which evaluates the experiences asked in the scale items in the last 2 weeks. The total scores obtained from the scale are 5, 10, and 15 cut-off points for mild, moderate, and severe anxiety, respectively.
The evaluation will take place in one interview (the interview will take 30 minutes)
Assessment of stress level with Perceived Stress Scale
Time Frame: The evaluation will take place in one interview (the interview will take 30 minutes)
Perceived Stress Scale will be used to determine stress level. Participants rate how often their lives were seen as unpredictable, uncontrollable, and overly intense during the previous month on the 5-point Likert scale (0 = Never, 4 = Very often). Total scores range from 0 to 40, with higher scores indicating a higher perceived stress level.
The evaluation will take place in one interview (the interview will take 30 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gülay Aras Bayram, asAss. Prof., Medipol University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 27, 2021

Primary Completion (Actual)

February 27, 2021

Study Completion (Actual)

February 27, 2021

Study Registration Dates

First Submitted

April 2, 2021

First Submitted That Met QC Criteria

April 5, 2021

First Posted (Actual)

April 8, 2021

Study Record Updates

Last Update Posted (Actual)

April 8, 2021

Last Update Submitted That Met QC Criteria

April 5, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • E-10840098-772.02-2682

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Therapy

Clinical Trials on A questionnaire and scales.

Subscribe